SCHEMBL3162870

SCHEMBL3162870

CC(=O)NCCNc1cc(NC(=O)C(=O)N2CCC(NC(=O)c3ccccc3)CC2)nc(-c2ccccc2)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.44
▸ MEN1 O00255 4/20 0.42
▸ KMT2A Q03164 4/20 0.42
▸ POLB P06746 3/20 0.42
▸ CTDSP1 Q9GZU7 1/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ CARM1 Q86X55 1/20 0.41
▸ PRMT6 Q96LA8 1/20 0.41
▸ CKS1B P61024 1/20 0.41
▸ SKP1 P63208 1/20 0.41
▸ SKP2 Q13309 1/20 0.41
▸ ADORA1 P30542 4/20 0.40
▸ ADORA2A P29274 3/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ P2RY12 Q9H244 1/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ MCHR1 Q99705 1/20 0.40
▸ ADORA3 P0DMS8 3/20 0.40
▸ ADORA2B P29275 1/20 0.40
▸ CHRM2 P08172 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3169774 0.89 ADORA2A (0.43) ADORA1ADORA2AP2RY12KDM4EADORA3
SCHEMBL3163481 0.88 ADORA2A (0.41) CKS1BSKP1SKP2ADORA1ADORA2A
SCHEMBL3162937 0.87 ADORA2A (0.46) ADORA1ADORA2AP2RY12KDM4EADORA3
SCHEMBL3165495 0.87 TDP1 (0.45) TDP1ADORA1ADORA2AKDM4EADORA3
SCHEMBL3174594 0.86 ADORA2A (0.45) ADORA1ADORA2AP2RY12KDM4EADORA3
SCHEMBL3175769 0.86 ADORA2A (0.45) ADORA1ADORA2AP2RY12KDM4EADORA3
SCHEMBL3166225 0.86 ADORA2A (0.45) ADORA1ADORA2AP2RY12KDM4EADORA3
SCHEMBL3171546 0.86 ADORA2A (0.40) POLBADORA1ADORA2AL3MBTL1ADORA3
SCHEMBL3172373 0.86 GRIN2D (0.49) NPSR1MEN1KMT2APOLBADORA1
SCHEMBL3155892 0.85 ADORA2A (0.46) ADORA1ADORA2AP2RY12KDM4EADORA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1465631-B1 PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE OSI PHARM INC (US) 2010-02-24 — — EP disclosed
Send feedback